The Value of Online CME in the Multidisciplinary Care of Patients with NTRK Fusion-Positive Thyroid Cancer

被引：0
|
作者：
Worst, M. A. [1 ]
Carothers, A. [1 ]
Surducan, M. [1 ]
Sipos, J. [2 ]
Wirth, L. [3 ]
机构：
[1] Medscape LLC, New York, NY USA
[2] Arthur G James Comprehens Canc Ctr, Columbus, OH USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 112卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
187
引用
收藏
页码：E50 / E51
页数：2
相关论文
共 50 条
  • [1] Real-World Experience of NTRK Fusion-Positive Thyroid Cancer
    Park, Jong Chul
    Ashok, Arya
    Liu, Chienying
    Kang, Hyunseok
    JCO PRECISION ONCOLOGY, 2022, 6
  • [2] NTRK fusion-positive colorectal cancer in Japanese population
    Yonemaru, Junpei
    Hashimoto, Taiki
    Takayanagi, Daisuke
    Naka, Tomoaki
    Yatabe, Yasushi
    Kanemitsu, Yukihide
    Shiraishi, Kouya
    Sekine, Shigeki
    PATHOLOGY INTERNATIONAL, 2021, 71 (05) : 355 - 359
  • [3] NTRK Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy
    Marczyk, Vicente R.
    Fazeli, Sasan
    Dadu, Ramona
    Busaidy, Naifa L.
    Iyer, Priyanka
    Hu, Mimi I.
    Sherman, Steven I.
    Hamidi, Sarah
    Hosseini, Sayed Mohsen
    Williams, Michelle D.
    Ahmed, Salmaan
    Routbort, Mark J.
    Luthra, Raja
    Roy-Chowdhuri, Sinchita
    San Lucas, Francis Anthony
    Patel, Keyur P.
    Hong, David S.
    Zafereo, Mark
    Wang, Jennifer R.
    Maniakas, Anastasios
    Waguespack, Steven G.
    Cabanillas, Maria E.
    JCO PRECISION ONCOLOGY, 2025, 9
  • [4] Management of Patients with NTRK Fusion- Positive Thyroid Cancer
    Wirth, Lori J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (06)
  • [5] Single-Institution Experience of Larotrectinib Therapy for Patients With NTRK Fusion-Positive Thyroid Carcinoma
    Elghawy, Omar
    Barsouk, Adam
    Heidlauf, Alec
    Chen, Simon
    Cohen, Roger B.
    Sun, Lova
    JOURNAL OF THE ENDOCRINE SOCIETY, 2024, 8 (10)
  • [6] Efficacy and safety of entrectinib in NTRK fusion-positive (NTRK-fp) breast cancer
    Lu, Janice
    Blakely, Collin M.
    Le Tourneau, Christophe
    Waqar, Saiama N.
    Bauer, Todd M.
    de Braud, Filippo
    Hong, David S.
    Spira, Alexander
    Tan, Tira
    McCallum, Samuel
    Osborne, Stuart
    Simmons, Brian
    Barve, Minal
    CANCER RESEARCH, 2021, 81 (04)
  • [7] Challenges in the Diagnosis of NTRK Fusion-Positive Cancers
    Gautschi, Oliver
    Bubendorf, Lukas
    Leyvraz, Serge
    Menon, Roopika
    Diebold, Joachim
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (07) : E107 - E109
  • [8] Entrectinib for ROS1 fusion-positive NSCLC and NTRK fusion-positive solid tumours
    Lassen, Ulrik
    LANCET ONCOLOGY, 2020, 21 (02): : 193 - 194
  • [9] Utility of NTRK RNA In Situ Hybridization in NTRK Fusion-Positive Tumors
    Boyraz, Baris
    Neyaz, Azfar
    Hornick, Jason
    Chebib, Ivan
    Deshpande, Vikram
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 817 - 818
  • [10] Utility of NTRK RNA In Situ Hybridization in NTRK Fusion-Positive Tumors
    Boyraz, Baris
    Neyaz, Azfar
    Hornick, Jason
    Chebib, Ivan
    Deshpande, Vikram
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 817 - 818
12345